• Bakul Patel, MSc, MBA SR. DIRECTOR, GLOBAL DIGITAL HEALTH STRATEGY & REGULATORY, GOOGLE

Current Status of Medicare Coverage for Emerging Technologies

• Perry Bridger, MHS SENIOR ADVISOR, PUBLIC AFFAIRS, EDWARDS LIFESCIENCES
• Mike Carusi, MBA GENERAL PARTNER & TEAM LEADER, LIGHTSTONE VENTURES (LSV)
• Steven Farmer, MD, PhD CHIEF STRATEGY OFFICER, COVERAGE & ANALYSIS GROUP, CMS
• Katie Meyer, MPP VICE PRESIDENT, GOVERNMENT AFFAIRS, NOVOCURE
• Randall Rutta, MA CEO, NATIONAL HEALTH COUNCIL

From Mandates to Movement: Bridging the Gap in Health Data Interoperability
 

• Jennifer Blumenthal PRODUCT DIRECTOR, MILLIMAN INTELLISCRIPT
• Brendan Keeler HEAD OF PRODUCT, FLEXPA
• Rob Klootwyk DIRECTOR, INTEROPERABILITY, EPIC
• Deven McGraw, JD, MPHCHIEF REGULATORY OFFICER, CIITIZEN

Artificial Intelligence and Healthcare

• Ramin Bastani CEO, HEALTHVANA
• Lana Feng, PhD  CO-FOUNDER & CEO, HUMA.AI
• Robin Strongin SENIOR DIRECTOR, NATIONAL, CONSUMERS LEAGUE
• Russell Wald DEPUTY DIRECTOR,
  STANFORD HAI

Current Policy Challenges Impacting Biotechnology Innovation

• Jeff Allen, PhD PRESIDENT & CEO, FRIENDS OF CANCER RESEARCH
• Peter Kolchinsky, PhD Managing Partner, RA Capital Management
• Ken Drazan, MD CHAIRMAN, CEO & CO-FOUNDER, ARSENALBIO
• Emil Kakkis, MD, PhD PRESIDENT & CEO, ULTRAGENYX PHARMACEUTICAL INC.
• Peter Marks, MD, PhD DIRECTOR, CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), US FDA

• Oliver Aalami, MD DIRECTOR, DIGITAL HEALTH, STANFORD BIODESIGN
• Michael Ackermann,
  PhD DIRECTOR, BIOTECH, STANFORD BIODESIGN
  
• Rohini Kosoglu, MPS DIRECTOR, POLITICAL AFFAIRS,  STANFORD BIODESIGN POLICY PROGRAM
  
• Josh Makower, MD Director & Co-Founder, Stanford Biodesign